ãã€ãªãã¯ãããžãŒäŒæ¥ã§ãã Cidara Therapeutics, Inc. ã¯ãç±³åœã«ãããç
æ°ã®æ²»çãšäºé²ã®ããã®æ°ããé·æäœçšåæææè¬ã®çºèŠãéçºãããã³åååã«æ³šåããŠããŸããå瀟ã®äž»å補ååè£ã¯ãã¬ã¶ãã¡ã³ã®ã³é
¢é
žå¡©ã§ããããã¯ãæ»äº¡çã®é«ãçèææçã§ããã«ã³ãžãè¡çã䟵襲æ§ã«ã³ãžãçãªã©ã®é節ãªäŸµè¥²æ§çèææçã®æ²»çãšäºé²ã®ããã®ãšãããã£ã³ãã£ã³ç³»æçèè¬ã®æ°ããååã§ãããŸããå瀟㯠Cloudbreak ãã©ãããã©ãŒã ãé²åãããã€ã³ãã«ãšã³ã¶ããã®ä»ã®ãŠã€ã«ã¹ææç (RS ãŠã€ã«ã¹ãHIVãCOVID-19 ã®åå ãšãªã SARS-CoV-2 æ ªãªã©) ã®äºé²ãšæ²»çã®ããã®æãŠã€ã«ã¹è€åäœã®éçºã«åãçµãã§ããŸããå瀟ã¯ä»¥åã¯K2 Therapeutics, Inc.ãšããŠç¥ãããŠããŸãããã2014幎7æã«Cidara Therapeutics, Inc.ã«ç€Ÿåã倿ŽããŸãããCidara Therapeutics, Inc.ã¯2012幎ã«èšç«ãããã«ãªãã©ã«ãã¢å·ãµã³ãã£ãšãŽã«æ¬ç€Ÿã眮ããŠããŸãã